Tangeretin suppresses HER2-driven breast cancer via PI3K/AKT/mTOR inhibition and caspase-dependent apoptosis. (2026). Bangladesh Journal of Pharmacology, 21(1), 1-10. https://doi.org/10.3329/bjp.v21i1.85717